Shelter Pharma’s Growth Analyzed
Shelter Pharma recently won a big order from a company called Taha Drugs & Chemicals. They’ll be making D3 Cure Capsules for about two months. This order is worth $27,540, and it’s a guaranteed amount, meaning Shelter Pharma will get paid no matter what.
Key Points
- Shelter Pharma secured a $27,540 order from Taha Drugs.
- Capsules will be produced within a two-month timeframe.
- Fixed-cost contract ensures a guaranteed payment for Shelter Pharma.
- Company’s growth is driven by increased sales and production.
- No related-party transactions or conflicts of interest exist.
- FY25 results show a 16.8% net profit increase.
Company Overview
Shelter Pharma makes herbal medicines and has a strong presence in both human and animal health. They make a wide variety of products, covering many parts of the human and animal medicine industries. This gives them a good spread of customers.
Financial Performance – FY25
Shelter Pharma’s profits jumped significantly. Their net profit increased by 16.8% to reach Rs 7.24 crore. This was thanks to a 26.6% rise in their total sales, which reached Rs 50.66 crore, compared to the previous year.
This financial success highlights Shelter Pharma’s strategic growth initiatives.
